BioGeNe Confex 2023

WHAT TO EXPECT

Commercialization of CDx
Proteomics and Genomics based Biomarkers
Biomarker Drug Discovery and Assay Development
Effective Microbiome Therapeutics in Production
Role of human skin microbiome in precision health
The increasing pro bacterial beauty industry
Business collaborations- Regulations and Investments
Novel horizons in biomarker strategies,
Liquid biopsy-based disease detection
Current Multi Omics analysis
Artificial Intelligence and Machine Learning
Gene expression Profiling in Precision Medicine
Multiplex Companion Diagnostics and Regulatory Guidelines
Design of clinical trials in CDx
Microbiome as a science and its clinical applications- skin, gut & women’s health
Prebiotics, Probiotics and Postbiotics

To share and exchange the recent trends and techniques in Personalized Medicine
Quality insights and cohesiveness of key issues and obstacles experienced by the healthcare providers while implementing Precision Medicine
Discover the different avenues in patient centric care
Access wide range of novel applications, innovative research, regulatory and policy development
Opportunity for one-on-one networking and extend professional competency with experts ranging from Government, Industry, Technology, Research and Healthcare providers
Be a part of the conversations via panel discussion with great lineup of experts

Researchers, scientists, clinicians, academicians and professionals from Pharmaceutical companies, Bio-pharma companies & Universities and Research institutes working in:

Biomarker discovery/development, Translational research, Clinical Biomarker, Biomarkers in IO and Neurological disorders, Imaging Biomarkers, Pathology, Companion Diagnostics, Biomarker Imaging, Proteomics Biomarkers, Experimental Medicine, Data Science. Microbiome discovery, Department of Biochemistry and Immunology, Microbiome science, Microbiology, Biological Science, Gut Biology, Human microbiome, Drug discovery, Therapeutics, Immunotherapy

Industry: Pharma/Therapeutic Companies/Start Up’s

CEOs, CMO’s, CSO’s, COO’s, Presidents, Vice Presidents, Directors, Managing Directors, Head of Departments, Executive Leaders, Pharmacists, Oncologists, Immunologists, Geneticists, Principal Scientists, Big Data Scientists, Business Development, Regulatory and Policy Advisors, Diagnostic Laboratory Professionals, Global Leaders.

Departments: Oncology, Personalized medicine, Immunology, Molecular Biology, Genetics and genomic medicine, Molecular Medicine, Pharmacogenomics, Biotechnology

Academics: Universities, Research Institutes, Hospitals

Head of Departments, Professors, Lecturers, Senior Scientists, Researchers, Bioinformaticians

Departments: Oncology, Personalized medicine, Immunology, Molecular Biology, Genetics and genomic medicine, Molecular Medicine, Pharmacogenomics, Biotechnology

CONFERENCE SPEAKERS

ADVISORS

Seth D. Crosby

Director, Research Collaborations, Washington University School of Medicine

Julius Goepp

Founder, CEO, Scaled Microbiomics

Arun K. Bhunia

Professor of Food Microbiology, Chair, Interdepartmental Food Science Graduate Program, Department of Food Science, Purdue Institute of Inflammation, Immunology and Infectious Disease

Peter Leighton

CEO, ProSperity Bioscience

Maya Ivanjesku

Chief Scientific Officer, Dakota Biotech

SPEAKERS

Tony Grover

Global Director, Biomarkers and CDx, BD Biosciences Biosciences

Deboleena Sarkar

Director Companion Diagnostics Business Development, Qiagen

Scott A. Jackson

Leader – Complex Microbial Systems Group, NIST - National Institute of Standards and Technology

Leigh A. Frame

Director, George Washington School of Medicine & Health Sciences

Larry Weiss

CEO and Founder, Persona Biome, Inc.

Yug Varma

CEO, Phi Therapeutics

Nicole M. Scott

CEO and Founder, Cybele Microbiome

Emily Stein

CEO, Primal Health Inc.

Arun K. Bhunia

Professor of Food Microbiology, Chair, Interdepartmental Food Science Graduate Program, Department of Food Science, Purdue Institute of Inflammation, Immunology and Infectious Disease